Logotype for Corline Biomedical

Corline Biomedical (CLBIO) investor relations material

Corline Biomedical Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Corline Biomedical
Q3 2025 earnings summary18 Nov, 2025

Executive summary

  • Achieved a breakthrough period with FDA approval for a partner's product using CHSTM technology and a 10-year license and supply agreement with Kardium.

  • Raised 23 MSEK through a directed share issue to Eiffel Investment Group to support expansion, especially in the US.

  • Focused on scaling production and ensuring quality to meet anticipated demand from Kardium and future customers.

Financial highlights

  • Net sales for Q3 2025 were 1,305 KSEK, down from 1,770 KSEK in Q3 2024; for Jan–Sep 2025, net sales were 5,547 KSEK, down from 7,763 KSEK year-over-year.

  • Result after financial items for Q3 2025 was -3,359 KSEK (Q3 2024: -2,996 KSEK); Jan–Sep 2025: -9,687 KSEK (Jan–Sep 2024: -9,033 KSEK).

  • Earnings per share for Q3 2025 were -0.14 SEK (unchanged year-over-year); Jan–Sep 2025: -0.40 SEK (-0.42 SEK year-over-year).

  • Cash and cash equivalents at September 30, 2025, were 5.8 MSEK (7.3 MSEK year-over-year).

  • Equity at period end was 77,227 KSEK (84,506 KSEK year-over-year); equity ratio 94% (91%).

Outlook and guidance

  • Anticipates increased revenues and financial stability from the long-term Kardium agreement and new capital injection.

  • Plans to expand the customer base in the US and Europe, reducing dependency on a single client.

  • Detailed commercial expansion plan for the US to be presented in Q1 2026.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Corline Biomedical earnings date

Logotype for Corline Biomedical
Q4 202517 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Corline Biomedical earnings date

Logotype for Corline Biomedical
Q4 202517 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Corline Biomedical AB is a Swedish biotechnology company focused on developing heparin-based medical solutions to improve outcomes in kidney transplantation and cell therapies. The company’s proprietary Corline Heparin Conjugate (CHC) technology is central to its product offerings. Key products include Renaparin, aimed at improving kidney transplantation by reducing complications during surgery, and Cytoparin, designed for cell therapy applications, particularly in the treatment of type 1 diabetes. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Stockholm Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage